Research suggests lowering cholesterol can reduce benign prostatic hyperplasia

Researchers at Children’s Hospital Boston report a cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH).

Study results suggest that lowering cholesterol has the potential to reduce BPH in men. This finding brings up the possibility that other cholesterol lowering therapies, including exercise and diet, may prevent BPH from developing

Cponclusions of the study are in the October issue of the Journal of Urology.